Culturelle® with Lactobacillus rhamnosus GG (LGG®) for Adults

Digestive, immune, and everyday health support for your adult patients

The probiotic LGG® has been extensively studied in adults and has proven benefits

Many conditions, from diarrhea to colitis, can be attributed to dysregulation of the gut microbiota.1-2 Fortunately, clinical studies have demonstrated that probiotics such as LGG® can help restore the balance.3-10 

Culturelle® products include 100% live LGG® – a unique strain of probiotic able to survive stomach acid and support a strong barrier against non-beneficial bacteria on the intestinal wall, providing a digestive advantage.11 With over 1,000 scientific studies and over 200 human clinical trials, LGG® has been more extensively studied than any other probiotic strain and proven safe and effective.11

Interested in additional clinical research and data for LGG® supplementation in adults? Learn more

The Culturelle® Advantage

When compared to other probiotics, Culturelle® offers more medical benefits, has undergone more research, and is less expensive for your adult patients.1-11

{CMS alt text}

 

Culturelle® offers products for both digestive and everyday health

Offering the most efficacious dose among leading brands and designed to promote ongoing digestive support as well as everyday wellness for your patients, all products in our line-up feature LGG®, the #1 clinically studied probiotic strain.11

Explore our wide range of products and learn why Culturelle® is the #1 selling probiotic brand in the U.S.11 Learn more

References
  • Quigley EM. Gut bacteria in health and disease. Gastroenterol Hepatol. 2013;9(9):560-569.  
  • Belkaid  Y. Hand T. Role of the Microbiota in Immunity and inflammation. Cell. 2014;157(1):121–141.
  • Segers ME, Lebeer S. Towards a better understanding of Lactobacillus rhamnosus GG - host interactions. Microbial Cell Factories. 2014;13(Suppl 1):S7-S23.
  • Davidson LE, Fiorino AM, Snydman DR, Hibberd PL. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr. 2011;65(4):501-507.
  • Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhea. Ann Med. 1990;22(1):57-59.
  • Gogineni VK, Lee E Morrow and Mark,A.Malesker. Probiotics: Mechanisms of action and clinical application. Journal of Probiotics & Health. 2013(1):1-11.
  • Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999;135:564-568.
  • Guandalini S, Pensabene L, Zikri MA, et al: Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. 2000 30(1):54–60.
  • Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2007;119(4):1019-1021.
  • Berni Canani R, Nocerino R, Terrin G, et al. Effect of Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: a randomized trial. J Allergy Clin Immunol. 2012;129(2):580-602.
  • Data on File. i-Health Inc, Cromwell, CT.